Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 187 of 6351
-
AI-Designed TB treatment aims for 99.5% cure rate
Disease control Not yet recruitingTuberculosis (TB) kills 1.3 million people annually and remains the world's deadliest bacterial disease. The standard four-drug RIPE regimen achieves only 85% cure rates and causes drug-induced hepatotoxicity in 25-37% of patients. Hydroxychloroquine (HCQ), an FDA-approved antima…
Phase 2 • Sponsor: Ministry of Health, Saudi Arabia • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New trial combines HIV PrEP and STI prevention in one package for young men
Disease control Not yet recruitingIndividual-Level Randomized Controlled Trial of an Integrated Strategy of HIV pre-exposure prophylaxis (PrEP) and sexually transmitted infection (STI) post-exposure prophylaxis (PEP) for Young Men
Phase 3 • Sponsor: HIV Prevention Trials Network • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Radiation boost may supercharge CAR T-Cell therapy against tough lymphoma
Disease control Not yet recruitingThis phase I trial tests the safety, side effects, and best dose of total body irradiation (TBI) in combination with standard of care lymphodepletion with cyclophosphamide and fludarabine before tisagenlecleucel (Tisa-cel) and how well the combination works in patients with large…
Phase 1 • Sponsor: Nathan Denlinger • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Two-Drug combo aims to shrink vulvar tumors before surgery
Disease control Not yet recruitingCOLOMBE is a multicenter, single arm, phase 1/2 trial designed to evaluate the safety and efficacy of imiquimod cream with IV low dose nivolumab in primary resectable vulvar squamous cell carcinoma patients prior to surgery, leveraging the preoperative "window of opportunity" per…
Phase 1/2 • Sponsor: Centre Leon Berard • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Can tailored brain zaps beat standard therapy for depression?
Disease control Not yet recruitingThe goal of this randomized clinical trial is to learn whether context-guided personalized intermittent theta burst stimulation (iTBS) works better than standard iTBS for adults with major depressive disorder. iTBS is a noninvasive treatment that uses magnetic pulses to stimulate…
Sponsor: Capital Medical University • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Can adding immunotherapy to chemotherapy improve gastric cancer outcomes?
Disease control Not yet recruitingTo address regional disparity, the investigators propose a tailored perioperative strategy for East Asian patients, combining neoadjuvant FLOT plus durvalumab, followed by adjuvant TS-1 plus durvalumab. This approach seeks to balance efficacy, immunologic synergy, and treatment t…
Phase 2 • Sponsor: Taipei Veterans General Hospital, Taiwan • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Can an Iron-Binding drug plus an antioxidant quiet Schizophrenia's 'Negative' symptoms?
Disease control Not yet recruitingIn following guidelines for studying negative symptoms in schizophrenia, 60 patients aged 18-40, diagnosed with schizophrenia or schizoaffective disorder during the last ten years, will receive a combination of the iron chelator DFP plus NAC or a matching placebo plus NAC combina…
Phase 2 • Sponsor: Amit Lotan • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Can sound waves supercharge immunotherapy against bile duct cancer?
Disease control Not yet recruitingThe purpose of this research is to evaluate whether adding histotripsy to maintenance durvalumab increases immune response and to assess the safety of this combination for participants with advanced intrahepatic cholangiocarcinoma (iCCA). Histotripsy is a non-invasive, non-therma…
Phase 2 • Sponsor: University of Wisconsin, Madison • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Can a daily pill tame a hidden heart risk?
Disease control Not yet recruitingThis study is designed to evaluate the efficacy and safety of HRS-5346 Tablets in participants with high cardiovascular event risk and elevated Lp(a), and to investigate the appropriate dosage of HRS-5346 Tablets
Phase 2 • Sponsor: Shandong Suncadia Medicine Co., Ltd. • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
Could a single dose of radiation rejuvenate failing hearts?
Disease control Not yet recruitingThe RADIATE-HF study is a prospective, interventional, single-center, open-label, non-randomized study conducted at the Rennes University Hospital. The goal of this proof-of-concept trial is to demonstrate that low-dose cardiac radiation therapy (5 Gy) improves left ventricular …
Sponsor: Rennes University Hospital • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
Magnetic pulses to the brain: a Drug-Free hope for peripartum depression?
Disease control Not yet recruitingThe goal of this clinical trial is to learn whether repetitive transcranial magnetic stimulation (rTMS) can reduce depressive symptoms in women who are pregnant or up to 12 months after childbirth and have peripartum depression. rTMS is a non-invasive treatment in which a device …
Sponsor: Psychiatric University Hospital, Zurich • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
Can a smart algorithm keep depression from returning?
Disease control Not yet recruitingThis proposal seeks to carry out a prospective, single-arm open label study aimed at sustaining treatment-resistant depression (TRD) response in patients with TRD who had responded to prior individualized resting-state functional connectivity (rs-FC)-guided intermittent theta bur…
Sponsor: National University Hospital, Singapore • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Can a Bladder-Instilled drug plus immunotherapy beat High-Risk bladder cancer?
Disease control Not yet recruitingThis study is an open-label, single-arm investigator-initiated clinical trial, aiming to evaluate the efficacy and safety of vicedetinib bladder instillation combined with teprotumumab in the treatment of patients with HER2-expressing, previously untreated, or BCG-resistant high-…
Phase 1 • Sponsor: Xiangya Hospital of Central South University • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
Can an oral pill tame a rare blood disease?
Disease control Not yet recruitingThis study aimed to evaluate the efficacy and safety of Lanoracopan Hydrochloride in the treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH)
Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
Could a daily mineral make liver cancer therapy work better?
Disease control Not yet recruitingThis study will look at whether adding daily oral zinc supplements to targeted therapy plus immunotherapy may help people with unresectable or advanced hepatocellular carcinoma, a common type of liver cancer. About 60 participants will take part in this study. Participants will …
Phase 2 • Sponsor: Anhui Provincial Hospital • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Stomach suturing may lighten the load on failing hearts
Disease control Not yet recruitingThis is a small research study to see whether losing weight with a minimally invasive weight-loss procedure called endoscopic sleeve gastroplasty (ESG) can help improve symptoms of a type of heart failure called HFpEF in adults with obesity.
Sponsor: Cedars-Sinai Medical Center • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Can an experimental infusion slow muscle loss in FSHD?
Disease control Not yet recruitingThe purpose of this study is to evaluate the safety, tolerability, and preliminary efficacy of SFL-0821 in adult patients with Facioscapulohumeral Muscular Dystrophy (FSHD)
Phase 1/2 • Sponsor: Soufflé Therapeutics, Inc. • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Can a gentle robotic pull retrain balance after stroke?
Disease control Not yet recruitingThe goal of this clinical trial is to learn if a treadmill gait training performed with a new robotic device will improve walking balance and everyday participation in walking activities for adults who have had a stroke. The main questions it aims to answer are: 1. Does treadmil…
Sponsor: Northwestern University • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
A Hormone-Free IVF path? Lab-Matured eggs put to the test
Disease control Recruiting nowThis study is testing whether eggs can be collected from small follicles without using the usual ovarian stimulation medications. Participants will have up to three egg retrieval procedures. The eggs collected during each retrieval will be matured in the laboratory using the CAPA…
Sponsor: Kevin Doody • Aim: Disease control
Last updated Sep 10, 2026 03:00 UTC
-
Can a new drug shorten Guillain-Barré recovery?
Disease control Not yet recruitingThe goal of this clinical trial is to evaluate the safety and effectiveness of Efgartigimod in patients with Guillain-Barre syndrome (GBS). The main questions it aims to answer are: Is Efgartigimod a safe treatment option for GBS patients? Does treatment with Efgartigimod improv…
Phase 2 • Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC